Volume 17, Issue 7, Pages (November 2016)

Slides:



Advertisements
Similar presentations
Volume 33, Issue 2, Pages (August 2010)
Advertisements

Volume 45, Issue 1, Pages (July 2016)
Volume 45, Issue 5, Pages (November 2016)
Volume 42, Issue 1, Pages (January 2015)
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Volume 47, Issue 1, Pages e8 (July 2017)
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 21, Issue 13, Pages (December 2017)
Volume 13, Issue 6, Pages (November 2015)
Volume 162, Issue 3, Pages (July 2015)
Volume 14, Issue 4, Pages (February 2016)
Volume 42, Issue 5, Pages (May 2015)
Volume 30, Issue 4, Pages (April 2009)
Volume 38, Issue 2, Pages (February 2013)
Volume 23, Issue 4, Pages (April 2018)
Volume 23, Issue 7, Pages (May 2018)
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Designing and Maintaining the Mature TCR Repertoire
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 33, Issue 2, Pages (August 2010)
Volume 31, Issue 1, Pages (July 2009)
Volume 42, Issue 2, Pages (February 2015)
Volume 153, Issue 4, Pages (May 2013)
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 45, Issue 1, Pages (July 2016)
Volume 21, Issue 9, Pages (November 2017)
Saskia Hemmers, Alexander Y. Rudensky  Cell Reports 
Volume 23, Issue 5, Pages (May 2018)
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 5, Pages (May 2008)
T Cell-Positive Selection Uses Self-Ligand Binding Strength to Optimize Repertoire Recognition of Foreign Antigens  Judith N. Mandl, João P. Monteiro,
Louise J. McHeyzer-Williams, Michael G. McHeyzer-Williams  Immunity 
Volume 38, Issue 6, Pages (June 2013)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 35, Issue 4, Pages (October 2011)
Volume 32, Issue 1, Pages (January 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 43, Issue 5, Pages (November 2015)
Volume 29, Issue 5, Pages (November 2008)
Volume 43, Issue 6, Pages (December 2015)
Volume 29, Issue 4, Pages (October 2008)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 46, Issue 4, Pages (April 2017)
Cecile King, Alex Ilic, Kersten Koelsch, Nora Sarvetnick  Cell 
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 35, Issue 1, Pages (July 2011)
Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity 
Volume 27, Issue 2, Pages (August 2007)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 16, Issue 12, Pages (September 2016)
Volume 30, Issue 4, Pages (April 2009)
Courtney R. Plumlee, Brian S. Sheridan, Basak B. Cicek, Leo Lefrançois 
Volume 38, Issue 6, Pages (June 2013)
Volume 87, Issue 2, Pages (October 1996)
Volume 32, Issue 1, Pages (January 2010)
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
Volume 40, Issue 3, Pages (March 2014)
Volume 35, Issue 4, Pages (October 2011)
Volume 13, Issue 6, Pages (November 2015)
Volume 25, Issue 12, Pages e5 (December 2018)
Volume 31, Issue 2, Pages (August 2009)
Volume 39, Issue 5, Pages (November 2013)
Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular Osteopontin  Mari L. Shinohara,
Volume 17, Issue 6, Pages (November 2016)
Volume 13, Issue 11, Pages (December 2015)
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Volume 45, Issue 5, Pages (November 2016)
Volume 20, Issue 6, Pages (June 2004)
Volume 8, Issue 2, Pages (August 2010)
Presentation transcript:

Volume 17, Issue 7, Pages 1783-1794 (November 2016) Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity  Tony T. Jiang, Tijana Martinov, Lijun Xin, Jeremy M. Kinder, Justin A. Spanier, Brian T. Fife, Sing Sing Way  Cell Reports  Volume 17, Issue 7, Pages 1783-1794 (November 2016) DOI: 10.1016/j.celrep.2016.10.042 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 PD-1 Deprivation Unleashes High-Affinity Self-Reactive CD4 T Cells to Exacerbate Autoimmunity (A) MOG:I-Ab tetramer mean fluorescence intensity (MFI) and PD-1 expression levels for MOG-specific CD4 T cells pooled from spleen and peripheral lymph nodes in 6- to 8-week-old naive B6 mice. Each data point represents the average tetramer and PD-1 staining intensity for cells from an individual mouse prior to exogenous MOG peptide stimulation. (B) Number of MOG-specific CD4 T cells, and their intensity of MOG:I-Ab tetramer staining, recovered from pooled brain and spinal cords of PD-1-deficient compared with wild-type mice 14 days after immunization with MOG35-55 peptide in complete Freund’s adjuvant (CFA). (C) EAE incidence (p < 0.001) and clinical score after immunization with MOG peptide with CFA for PD-1-deficient compared with wild-type mice. (D) p31:I-Ag7 tetramer MFI and PD-1 expression levels for peripheral chromogranin A-specific CD4 T cells pooled from the spleen and peripheral lymph nodes of 13- to 16-week-old NOD mice. (E) Insulin:I-Ag7 tetramer MFI and PD-1 expression levels for peripheral insulin-specific CD4 T cells pooled from the spleen and peripheral lymph nodes of 15- to 18-week-old NOD mice. (F) Number of insulin-specific CD4 T cells, and their intensity of insulin:I-Ag7 tetramer staining, recovered from the pancreas of 5-week-old NOD mice treated with PD-1-neutralizing antibody or controls. Animals lacking insulin-specific CD4 T cells in the pancreas were not included in the analysis of insulin:I-Ag7 tetramer staining intensity. (G) Diabetes onset incidence (p < 0.0001) for PD-1-deficient compared with wild-type mice on the NOD background. The error bar represents 1 SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, using non-parametric Mann-Whitney U test. See also Figures S1 and S2. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 Activation and Expansion of High-Affinity CD4 T Cells following Cognate Self-Antigen Stimulation (A) Schematic used to identify donor (CD45.2) self-reactive CD4 T cells with 2W1S:I-Ab specificity in CD45.1 recipient mice that ubiquitously express 2W1S as a transmembrane recombinant protein in all cells under the β-actin promoter (Act-2W1S mice). (B) Representative fluorescence-activated cell sorting (FACS) plots and composite analyses of CD4 T cells with 2W1S:I-Ab specificity recovered from the spleen and peripheral lymph nodes of Act-2W1S recipients at the indicated time points after intravenous transfer of 107 donor (CD45.2) CD4 T cells. (C) Percent CD44+, 2W1S:I-Ab tetramer MFI, CD3 MFI, and 2W1S:I-Ab TCR affinity (tetramer MFI divided by CD3 MFI) for donor 2W1S-specific CD4 T cells pre- and post-transfer, compared with cells of the same specificity in recipient mice. The error bar represents 1 SEM. See also Figures S3 and S4. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 Autoreactive CD4 T Cells Acquire Self-Tolerance in Response to Cognate Antigen Stimulation in Peripheral Tissues (A) Schematic for probing the response of donor self-reactive CD4 T cells with 2W1S:I-Ab specificity to Lm-2W1S priming within congenically discordant Act-2W1S recipients. (B) Number of donor (CD45.2) 2W1S-specific CD4 T cells recovered following transfer into wild-type or Act-2W1S CD45.1 recipient mice 8 days after Lm-2W1S challenge compared with no-infection naive control mice. (C) Schematic showing ex vivo stimulation of donor self-reactive CD4 T cells with 2W1S:I-Ab specificity recovered from Act-2W1S recipient mice. (D) Representative FACS plots and composite analysis comparing IFN-γ and IL-2 production between CD4 T cells with self-2W1S or irrelevant bulk specificity after PMA-ionomycin stimulation. The error bar represents 1 SEM. ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, using non-parametric Mann-Whitney U test. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 PD-1 Reinforces Self-Tolerance among Self-Reactive CD4 T Cells (A) Cell-intrinsic expression of each molecule by donor self-reactive CD4 T cells with 2W1S:I-Ab specificity (black line) compared with irrelevant bulk specificity (shaded), 30 days after transfer into Act-2W1S recipients. (B) Schematic illustrating adoptive transfer of donor PD-1-deficient or wild-type CD4 T cells into Act-2W1S recipients, followed by Lm-2W1S challenge 30 days after transfer; and number of donor self-reactive CD4 T cells with 2W1S:I-Ab specificity in spleen and peripheral lymph nodes of mice 8 days after Lm-2W1S challenge compared with no-infection naive control mice. The error bar represents 1 SEM. ∗∗∗∗p < 0.0001, using non-parametric Mann-Whitney U test. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 5 PD-1 Expression Promotes Durable Cell-Intrinsic Self-Tolerance among Self-Reactive CD4 T Cells (A) Schematic showing initial transfer of one mouse equivalent donor CD45.2 CD4 T cells (107 cells) into Act-2W1S CD45.1 recipients, with secondary transfer into wild-type recipients followed by Lm-2W1S priming. (B) Donor 2W1S-specific CD4 T cells in the spleen and peripheral lymph nodes 8 days after Lm-2W1S challenge compared with no-infection naive control mice. (C) PD-1 expression by CD4 T cells with 2W1S (black line) or irrelevant bulk (shaded) for the mice described in (A) and (B). (D) Schematic showing initial transfer of one mouse equivalent donor CD45.2 CD4 T cells (107 cells) into Act-2W1S CD45.1 recipient mice, and secondary transfer into irradiated wild-type recipients followed by Lm-2W1S challenge after 15–20 days (HP) or >100 days (post-HP). (E) Donor 2W1S-specific CD4 T cells recovered from the spleen and peripheral lymph nodes enumerated 8 days post Lm-2W1S challenge compared with no-infection naive control mice. (F) PD-1 expression by CD4 T cells with 2W1S (black line) or irrelevant bulk (shaded) specificity for the mice described in (D) and (E). The error bar represents 1 SEM. ∗p < 0.05, using non-parametric Mann-Whitney U test. See also Figures S5 and S6. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 6 An Initial Wave of Self-Reactive T Cells That Bypass Clonal Deletion Does Not Impede the Expansion and Activation of Subsequent Self-Reactive Cells with Overlapping Specificity (A) Schematic showing two distinct cohorts of congenically discordant donor CD4 T cells (one mouse equivalent, 107 each donor cell type) transferred into the same Act-2W1S recipient mouse 30 days apart. (B) Accumulation of self-reactive CD4 T cells with 2W1S:I-Ab specificity from each donor subset in Act-2W1S recipients. (C) Comparison of 2W1S:I-Ab tetramer staining intensity and PD-1 expression among 2W1S-specific CD4 T cells from each donor subset or recipient mice at the indicated time points posttransfer. The error bar represents 1 SEM. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions

Figure 7 PD-1 Dampens Peripheral Accumulation of Individual Autoreactive CD4 T Cell Clones Based on TCR Self-Antigen Affinity (A) Schematic showing transfer of individual donor CD4 T cells with 2W1S:I-Ab specificity into congenically discordant Act-2W1S recipients. (B) Correlation between PD-1 MFI and clonal burst size, and between PD-1 MFI and 2W1S:I-Ab TCR affinity, for each self-reactive CD4 T cell clone derived from a polyclonal repertoire. (C) Schematic showing transfer of individual CD4 T cells with 2W1S:I-Ab specificity from either wild-type or PD-1-deficient donors into congenically discordant Act-2W1S recipients. (D) Clonal burst size and 2W1S:I-Ab TCR affinity for individual self-reactive CD4 T cell clones with or without cell-intrinsic PD-1 expression 8 days after transfer. (E) Two-dimensional analysis of clonal burst size and TCR affinity for individual donor CD4 T cell clones with 2W1S:I-Ab specificity described in (C) and (D). The error bar represents 1 SEM. ∗p < 0.05, ∗∗p < 0.01, using non-parametric Mann-Whitney U test for (D) and multivariable ANOVA for (E). See also Figure S7 and Table S1. Cell Reports 2016 17, 1783-1794DOI: (10.1016/j.celrep.2016.10.042) Copyright © 2016 The Author(s) Terms and Conditions